AbbVie News

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 20 19:33 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 18 17:07 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 1 19:55 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 1 16:28 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 29 18:09 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 29 17:39 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 29 16:17 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 28 18:04 ET

AbbVie | 424B5: Prospectus

Feb 26 06:15 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 23 16:10 ET

AbbVie | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 23 06:04 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 21 18:02 ET

AbbVie | 424B5: Prospectus

Feb 21 08:40 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 2 17:52 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 26, 2023 00:00 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 31, 2023 16:04 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 31, 2023 16:01 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 25, 2023 16:30 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 25, 2023 16:16 ET

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 17, 2023 17:42 ET